Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infanrix Hexa vs Co-administered DTPa-IPV/Hib + HBV in Infants
NCT00880477Phase 3Completed
- Sponsor
- GSK
- Start
- Jan 2001
- Primary completion
- Nov 2002
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
01
Overview
A Phase 3 trial of pertussis filamentous haemagglutinin in diphtheria, Tetanus, pertussis, hepatitis B (HBV), poliomyelitis, sponsored by GSK. Started Jan 2001; status: completed.
02
Drugs
pertussis filamentous haemagglutinin
03
Conditions
diphtheriaTetanuspertussishepatitis B (HBV)poliomyelitis
Beyond the preview
Go deeper on NCT00880477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00880477.